{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-101984","form_type":"8-K","ticker":null,"cik":"0000786947","company_name":"ACURA PHARMACEUTICALS, INC","filed_at":"2025-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.158435+00:00","generated_at":"2026-05-17T02:23:50.887636+00:00","sec_items":["1.01","2.01","2.03","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Acura borrows additional $300k from AD Pharma; warns of potential bankruptcy by early Nov 2025","bullets":["Principal balance on amended secured note reaches $8,994,279, with ~$865k accrued interest at 5.25%.","Three new $100k loans from AD Pharma (Sept 12, Oct 6, Oct 23 2025) used for day-to-day operations.","Without additional financing by early November 2025, company will need to scale back, furlough or terminate operations.","AD Pharma, which owns ~65% of Acura's common stock, is controlled by Mr. Schutte.","Interest rate on overdue amounts jumps to 7.5% per annum upon default."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-101984","json":"https://secwatch.observer/filing/0001104659-25-101984.json","markdown":"https://secwatch.observer/filing/0001104659-25-101984.md","text":"https://secwatch.observer/filing/0001104659-25-101984.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/786947/000110465925101984/0001104659-25-101984-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/786947/000110465925101984/tm2529376d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:23:50.887636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f461460481b87f9633b7148bb6efb17ec32247bf","claim":"ACURA PHARMACEUTICALS, INC incurred loan of $100,000 with Abuse Deterrent Pharma, LLC at 5.25%.","evidence_excerpt":"On each of September 12, 2025, October 6, 2025 and October 23, 2025 we received loans of $100,000 from Abuse Deterrent Pharma, LLC","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/786947/000110465925101984/0001104659-25-101984-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$100,000"},{"label":"Counterparty","value":"Abuse Deterrent Pharma, LLC"},{"label":"Rate","value":"5.25%"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}